AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇹🇳
INFLIXIMAB in Tunisia
2 products registered with DPM — 0 active, 2 expired
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| REMSIMA Pdre p.prep.injectable / 100 mg | 6653671H | HIKMA Pharmaceuticals | expired | 5 Jul 2017 |
| REMICADE Pdre p.prep.injectable / 100 mg | 1923011H | JANSSEN BIOLOGICS B.V | expired | 25 Aug 2003 |
INFLIXIMAB — DPM Registration Details
DPM (Tunisia) has 2 registered products containing INFLIXIMAB, of which 0 are currently active. Data is sourced directly from the official DPM drug register and refreshed daily.
Track INFLIXIMAB registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.